✦ LIBER ✦

P.3.d.001 Aripiprazole's receptor-reserve dependent antagonist properties at human dopamine D2 receptors

✍ Scribed by Y. Tadori; H. Kitagawa; A. Forbes; R. McQuade; A. Stark; T. Kikuchi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Receptor reserve-dependent properties of

✍ Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 557 KB

P.3.d.001 In-vitro pharmacology of aripi

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB

P.3.d.002 Characterization of aripiprazo

✍ Y. Tadori; A. Forbes; R. McQuade; T. Kikuchi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Differences in agonist/antagonist proper

✍ Yoshihiro Tadori; Hisashi Kitagawa; Robert A. Forbes; Robert D. McQuade; Arlene 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Functional potencies of dopamine agonist

✍ Yoshihiro Tadori; Robert A. Forbes; Robert D. McQuade; Tetsuro Kikuchi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 625 KB

Aripiprazole and its human metabolite ar

✍ Martyn D. Wood; Claire Scott; Kirsten Clarke; Julie Westaway; Ceri H. Davies; Ch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 323 KB